PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18834226-3 2008 OBJECTIVE: To investigate and compare the molecular and clinicopathologic features of CIMP-positive colorectal cancers defined by classic (p16, hMLH1, MINT1, MINT2, MINT31) and new (CACNA1G, IGF2, NEUROG1, RUNX3, SOCS1) CIMP panels. Cyclic IMP 86-90 RUNX family transcription factor 3 Homo sapiens 206-211 18628431-6 2008 Tumors were classified as CIMP positive when at least three of five markers (RUNX3, CACNA1G, SOCS1, NEUROG1, and IGF2) were methylated according to MethyLight analysis. Cyclic IMP 26-30 RUNX family transcription factor 3 Homo sapiens 77-82 28542846-3 2017 CIMP status was determined by analyzing the 5-markers CAGNA1G, IGF2, NEUROG1, RUNX3 and SOCS1 by quantitative methylation specific PCR (qMSP). Cyclic IMP 0-4 RUNX family transcription factor 3 Homo sapiens 78-83 17898258-8 2007 The rates for the CIMP-related genes were 25% for RUNX3, 5% for NEUROG1 and CACNA1G, and 0 for SOCS-1 and IGF-2. Cyclic IMP 18-22 RUNX family transcription factor 3 Homo sapiens 50-55 17270239-6 2007 After stratification by sex, location, tumor differentiation, RUNX3 status, KRAS/BRAF status, or p53 status, CIMP-high was persistently correlated with TGFBR2 mutation. Cyclic IMP 109-113 RUNX family transcription factor 3 Homo sapiens 62-67 21791485-7 2012 The promoter regions of subset of genes highly specific to characterize the CIMP status (NEUROG1, IGF2, RUNX3, SOCS1, including MLH1) were hypermethylated, suggesting the presence of CIMP+ and MSI high tumor. Cyclic IMP 76-80 RUNX family transcription factor 3 Homo sapiens 104-109 26702772-5 2016 CIMP status was determined using the DNA methylation status of CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1. Cyclic IMP 0-4 RUNX family transcription factor 3 Homo sapiens 87-92 21068132-8 2011 The CIMP marker RUNX3 was the earliest CpG island showing significant change, followed by the CIMP markers NEUROG1 and CACNA1G at the hyperplastic polyp stage. Cyclic IMP 4-8 RUNX family transcription factor 3 Homo sapiens 16-21